Search

Search Results

• 

  Pulmonary adverse events due to immune checkpoint inhibitors: A literature review

  Vasiliki Epameinondas Georgakopoulou, Nikolaos Garmpis, Dimitrios Mermigkis, Christos Damaskos, Serafeim Chlapoutakis, Konstantinos Mantzouranis, Aikaterini Gkoufa, Chrysovalantis Papageorgiou, Anna Garmpi, Sotiria Makrodimitri, Evangelos Diamantis, Pagona Sklapani, Nikolaos Trakas, Xanthi Tsiafaki

  2021-10-11

  https://doi.org/10.4081/monaldi.2021.2008

  2048

  PDF: 972
• 

  Interstitial nephritis secondary to treatment with pembrolizumab, a rare complication in two patients with lung adenocarcinoma

  Diana Alexandra Gonçalves Pimenta, Renata Carvalho, Raquel Pereira, Rui Rolo, Lurdes Ferreira

  2022-07-28

  https://doi.org/10.4081/monaldi.2022.2368

  1082

  PDF: 413

• Programmed cell death-ligand 1 expression and CD8 positive tumor-infiltrating lymphocyte density in non-small cell lung carcinoma and its association with histopathological grading

  Niti Sureka, Sheetal Arora, Pranav Ish, Geetika Khanna

  2025-02-21

  https://doi.org/10.4081/monaldi.2025.3288

  416

  PDF_EARLY VIEW: 120

• Optimal treatment strategies for coronary heart disease in cancer patients: a complex clinical case

  Elena Zelikovna Golukhova, Inessa Viktorovna Slivneva, Andrey Lvovich Pylev, Olga Sergeevna Kozlova, Karen Valerievich Petrosyan, Denis Sergeevich Romanov, Alexander Yurievich Volkov

  2024-09-12

  https://doi.org/10.4081/monaldi.2024.3149

  370

  PDF_EARLY VIEW: 143

• The role of immunotherapy in patients with lung cancer and brain metastases: a narrative review of the literature

  Eleni D. Eleftheriadou, Maria Saroglou, Nikolaos Syrigos, Ellias Kotteas, Marousa Kouvela

  2024-07-26

  https://doi.org/10.4081/monaldi.2024.2967

  460

  PDF_EARLY VIEW: 184